Related content

Pyrosequencing™-based screening for genetic polymorphisms in cytochrome P450 2B6 of potential clinical relevance

By Rohrbacher Maren   Kirchhof Anja   Geisslinger Gerd   Lötsch Jörn  

Pharmacogenomics, Vol. 7, Iss. 7, 2006-10 ,pp. : 995-1002

Future Medicine

Access to resources Recommend Favorite

Genetic polymorphism of CYP2D6 and CYP2C19 in East- and Southern African populations including psychiatric patients

By Dandara Collet   Mutowembwa Masimirembwa Collen   Magimba Ayoub   Sayi Jane   Kaaya Sylvia   Sommers De K.   Snyman J.R.   Hasler Julia Anne  

European Journal of Clinical Pharmacology, Vol. 57, Iss. 1, 2001-04 ,pp. : 11-17

Springer Publishing Company

Access to resources Recommend Favorite

Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitro

By Desta Zeruesenay   Saussele Tanja   Ward Bryan   Blievernicht Julia   Li Lang   Klein Kathrin   Flockhart David A   Zanger Ulrich M  

Pharmacogenomics, Vol. 8, Iss. 6, 2007-06 ,pp. : 547-558

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetic Prediction of Individual Variability in Drug Response Based on CYP2D6, CYP2C9 and CYP2C19 Genetic Polymorphisms

By  

Current Drug Metabolism, Vol. 15, Iss. 7, 2014-09 ,pp. : 711-718

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Polymorphism in Cytochrome P450 2D6 (CYP2D6): Population Distribution of CYP2D6 Activity

By Neafsey Patricia  

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 12, Iss. 5-6, 2009-05 ,pp. : 334-361

Taylor & Francis Ltd

Access to resources Recommend Favorite